We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACONW market cap is 286.65k. The company's latest EPS is USD -0.5585 and P/E is -0.07.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 19k | 13k | 10k | 11k | 14k |
Operating Income | -1.16M | -1.13M | -1.28M | -1.14M | -1.3M |
Net Income | -998k | -1.27M | -2.4M | -1.24M | -1.38M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 49k | 60k | 60k | 75k |
Operating Income | -4.48M | -2.95M | -6.1M | -4.88M |
Net Income | -5.49M | -4.95M | -8.02M | -4.91M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 1.54M | 2.46M | 3.73M | 3.09M | 3.19M |
Total Liabilities | 2.37M | 3.19M | 1.22M | 1.45M | 678k |
Total Equity | -828k | -728k | 2.51M | 1.64M | 2.51M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.29M | 1.89M | 3.21M | 2.46M |
Total Liabilities | 8.38M | 7.62M | 1.42M | 3.19M |
Total Equity | -7.08M | -5.73M | 1.79M | -728k |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -2.91M | -3.65M | -2.24M | -3.29M | -4.35M |
Investing | -86k | -120k | -64k | -158k | -261k |
Financing | 1.69M | 3.32M | 3.41M | 3.6M | 4.9M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -3.8M | -2.35M | -5.31M | -3.65M |
Investing | -179k | -152k | -208k | -120k |
Financing | 3.86M | 2.94M | 6.55M | 3.32M |
Market Cap | 286.65k |
Price to Earnings Ratio | -0.07 |
Price to Sales Ratio | 4.71 |
Price to Cash Ratio | 0.34 |
Price to Book Ratio | -0.48 |
Dividend Yield | - |
Shares Outstanding | 8.79M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (2.93%) |
Company Name | Aclarion Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.aclarion.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions